Report on rewards and incentives under the Paediatric Regulation

The Paediatric Regulation (Regulation (EC) No 1901/2006) provides incentives and rewards to companies that have undertaken research into, and the development and authorisation of pharmaceuticals for children. The Commission is obligated to report on companies and products that have benefited from those rewards and incentives as well as on companies that have failed to comply with any of the obligations in the Regulation (Article 50(1) of the Regulation). In this regard the European Medicines Agency has compiled a report, which covers the first three years of the Paediatric Regulation from its entry into force to 2009.